SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-16-008746
Filing Date
2016-04-08
Accepted
2016-04-08 14:40:42
Documents
13
Period of Report
2016-04-08
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 7867920
2 annexb_01.jpg GRAPHIC 48584
3 annexb_02.jpg GRAPHIC 3389
4 annexc_04.jpg GRAPHIC 6144
5 image_002.jpg GRAPHIC 4340
6 image_003.jpg GRAPHIC 6363
7 image_a001.jpg GRAPHIC 2888
8 image_a002.jpg GRAPHIC 2916
9 image_a003.jpg GRAPHIC 11091
10 image_a004.jpg GRAPHIC 6383
11 img1.jpg GRAPHIC 2566
12 proxycard_001.jpg GRAPHIC 271743
13 proxycard_002.jpg GRAPHIC 133410
  Complete submission text file 0001493152-16-008746.txt   8558897
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-18188 | Film No.: 161562396
SIC: 2836 Biological Products, (No Diagnostic Substances)